Balance Sheet Data

Alpine Immune Sciences, Inc. (ALPN)

$8.01

-0.15 (-1.84%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 81.2452.3040.52105.58120.772,027.375,449.3714,647.3739,370.70105,824.58
Total Cash (%)
Account Receivables 0.130.240.690.392524.1064.78174.12468.021,257.99
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 0.191.721.540.583.3545.84123.22331.20890.232,392.85
Accounts Payable (%)
Capital Expenditure -0.59-0.50-0.82-0.80-9.37-25.18-67.68-181.92-488.99-1,314.34
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.